Sign inJoin waitlistJoin the waitlist

Joseph Curry

Otolaryngology – Head/Neck Cancer · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY

Credentials: · · · · · ·

History

SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Present
Research · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Present
SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Present

University of Miami Hospitals & Clinic
2010–2011
Thomas Jefferson University Hospital
2009–2010
Otolaryngology - Head and Neck Surgery
SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
2004–2009
Drexel University College of Medicine
Georgetown University School of Medicine
2000–2004

Research

Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development
Review · Seminars in Oncology · 2017 · 275 citations
Tumor microenvironment in head and neck squamous cell carcinoma
Seminars in Oncology · 2014 · First of 7 authors · Corresponding · 225 citations
Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer
Cell Cycle · 2013 · First of 11 authors · Corresponding · 203 citations

Adam Luginbuhl
124 papers · 6 as a fellow
DC
David Cognetti
100 papers · 4 as a fellow
Jennifer Johnson
39 papers · 2 as a fellow
MT
Madalina Tuluc
39 papers
Ubaldo Outschoorn
31 papers
Ramez Philips
30 papers · 28 as a resident
MW
Mark Wax
27 papers
Ryan Heffelfinger
27 papers · 1 as a fellow
VB
Voichita BarAd
26 papers
Brian Swendseid
25 papers · 25 as a resident
Larissa Sweeny
25 papers · 2 as a fellow
Patrick Tassone
23 papers · 18 as a resident

Grants

Microbubble Augmentation of Immunotherapy in Head and Neck Cancer
National Cancer Institute · R21
PI · $401.1K · Thomas Jefferson University
2026–2028

Clinical trials

Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer
Principal investigator · Recruiting · Phase 1
Thomas Jefferson University
2026–2028
Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery
Principal investigator · Suspended · Phase 2
Thomas Jefferson University
2023–2031
Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma
Principal investigator · Completed · Early phase 1
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
2018–2022
Metformin to Mitigate Sequelae of Radioactive Iodine Treatment for Thyroid Cancers
Principal investigator · Terminated · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
2017–2022